Vicus Capital Novartis Ag Transaction History
Vicus Capital
- $1.09 Billion
- Q1 2024
A detailed history of Vicus Capital transactions in Novartis Ag stock. As of the latest transaction made, Vicus Capital holds 3,186 shares of NVS stock, worth $346,413. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,186
Previous 3,134
1.66%
Holding current value
$346,413
Previous $316,000
2.53%
% of portfolio
0.03%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding NVS
# of Institutions
1,359Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.35 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.34 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$789 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$654 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$643 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $234B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...